MedTrace Logo

A Study of ALRT1057 in Patients With AIDS-Related Kaposi's Sarcoma

NCT00002188 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 27

Last updated 2005-06-24

No results posted yet for this study

Summary

The purpose of this study is to see if ALRT1057 is safe and effective in treating patients with AIDS-related Kaposi's sarcoma (KS).

Conditions

  • Sarcoma, Kaposi
  • HIV Infections

Interventions

DRUG

Alitretinoin

Sponsors & Collaborators

  • Ligand Pharmaceuticals

    collaborator INDUSTRY

  • Anderson Clinical Research

    lead INDUSTRY

Study Design

Purpose
TREATMENT

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00002188 on ClinicalTrials.gov